ArticleRadiation oncology (London, England)2022

Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study.

Yuta Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.